Serum Magnesium Levels in Preeclampsia and Eclampsia Patients During Magnesium Sulfate Therapy

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 31

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JOGCR-10-1_006

تاریخ نمایه سازی: 11 دی 1403

چکیده مقاله:

Background and Objective: Pre-eclampsia is one of the pregnancy complications that can result in maternal and neonatal morbidity and mortality. Magnesium sulfate (MgSO۴) is one of the effective drugs to prevent and stop seizures in pre-eclampsia and eclampsia.  This study aimed to investigate the characteristics of patients with pre-eclampsia and eclampsia and serum magnesium levels during MgSO۴ therapy.Methods: A cross-sectional study design used secondary data from the Emergency Maternity Room of Prof. Dr. I.G.N.G. Ngoerah Hospital. The samples were all superimposed pre-eclampsia, severe pre-eclampsia, and eclampsia cases in ۲۰۱۹. We collected and analyzed characteristic and laboratory data, including the MgSO۴ serum levels of the patients. Participants' baseline characteristics (CBC, blood chemistry, and MgSO۴) and their diagnosis were compared using the chi-square test for categorical data and the independent t-test for numerical data.Results: The patients with severe pre-eclampsia were ۱۸۳ patients, superimposed pre-eclampsia were ۴۱ patients, and eclampsia ۱۵ patients. Age <۳۵ years old was the most influential characteristic variable in superimposed pre-eclampsia (adjusted odds ratio (aOR)=۰.۱۶۶, P<۰,۰۰۱, ۹۵%CI=۰.۰۸۲-۰.۳۳۶) and severe pre-eclampsia (aOR=۳.۰۱۱, p<۰,۰۰۱, ۹۵%CI=۱.۶۶۲-۵.۴۵۵). Hospital referrals were the most influential characteristic variable in eclampsia (aOR=۳.۶۵۳, P=۰.۰۱۶, ۹۵%CI=۱.۲۷۳-۱۰.۴۸۶). The administration of MgSO۴ was significant with severe pre-eclampsia (P<۰.۰۰۱). The highest serum magnesium occurred ۶ hours before MgSO۴ administration (۳.۹۷ ± ۱.۲۸ mg/dL).Conclusion: Patients with superimposed pre-eclampsia, severe pre-eclampsia, and eclampsia conditions have various characteristics associated with each state. During the use of MgSO۴, there was a significant association between serum magnesium levels and the therapeutic target levels.

نویسندگان

Anak Agung Ngurah Jaya Kusuma

Maternal Fetal Medicine Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Udayana, Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Indonesia

Endang Sri Widiyanti

Maternal Fetal Medicine Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Udayana, Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Indonesia

I Gede Mega Putra

Urogynecology and Reconstructive Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Udayana, Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Indonesia

Kadek Ary Widayana

Department of Obstetrics and Gynecology, Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Indonesia

William Alexander Setiawan

Department of Obstetrics and Gynecology, Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar, Indonesia

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Desetyaputra DR, Budi Prasetyo B, Damayanti HE. Root cause analysis ...
  • Bachnas MA, Sulistyowati S, Akbar U. Correlation between antenatal magnesium ...
  • Long Q, Oladapo OT, Leathersich S, Vogel JP, Carroli G, ...
  • Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, ...
  • Arumugam SC, Takkellapati A, John LB. Magnesium Sulfate Toxicity-Are Serum ...
  • Yefet E, Braester Y, Suleiman A, Nachum Z. ۸۸۴: The ...
  • Okusanya BO, Oladapo OT, Long Q, Lumbiganon P, Carroli G, ...
  • Guedes-Martins L. Superimposed Preeclampsia. Adv Exp Med Biol. ۲۰۱۷;۹۵۶:۴۰۹-۱۷. [DOI:۱۰.۱۰۰۷/۵۵۸۴_۲۰۱۶_۸۲] ...
  • Akbar MIA, Yoseph DA, Bachnas MA, Dachlan EG, Dekker GA, ...
  • Gumilar E, Kuntoro, Soeroso J, Dekker G, Ernawati. Expectant management ...
  • Kartika AR, Akbar MIA, Umiastuti P. Risk factor of severe ...
  • Tessema GA, Tekeste A, Ayele TA. Preeclampsia and associated factors ...
  • Shan D, Qiu PY, Wu YX, Chen Q, Li AL, ...
  • Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated ...
  • Belay Tolu L, Yigezu E, Urgie T, Feyissa GT. Maternal ...
  • Motedayen M, Rafiei M, Rezaei Tavirani M, Sayehmiri K, Dousti ...
  • Mrema D, Lie RT, Østbye T, Mahande MJ, Daltveit AK. ...
  • Maeda Y, Kaneko K, Ogawa K, Sago H, Murashima A. ...
  • Adeline ME, Laksana MAC, Atika S. Characteristic of Referral Patients ...
  • Ceyhan T, Beyan C, Başer I, Kaptan K, Güngör S, ...
  • Bulbul M, Uckardes F, Karacor T, Nacar MC, Kaplan S, ...
  • Kusuma A, Widiyanti E, Pranamartha A, Damanik A. High ratio ...
  • Canzoneri BJ, Lewis DF, Groome L, Wang Y. Increased neutrophil ...
  • Weissgerber TL, Mudd LM. Preeclampsia and diabetes. Curr Diab Rep. ...
  • Kametas NA, Nzelu D, Nicolaides KH. Chronic hypertension and superimposed ...
  • Euser AG, Cipolla MJ. Magnesium sulfate for the treatment of ...
  • Allen MJ, Sharma S. Magnesium: StatPearls Publishing; ۲۰۲۰ ...
  • Pascoal ACF, Katz L, Pinto MH, Santos CA, Braga LCO, ...
  • Beyuo TK, Lawrence ER, Kobernik EK, Oppong SA. A novel ...
  • Beru Brahmana I, Inayati I. Vaginal Discharge in Pregnancy: The ...
  • نمایش کامل مراجع